Background
Kidney transplantation has superior effects on decreasing patients’ mortality and improving quality of life for patients with end-stage kidney disease [
1]. However, kidney transplant recipients (KTRs) are at high risk of rejection and complications [
2]. They need to adhere to complex medication treatment regimens [
3], monitor their physical conditions, and perform regular and lifelong follow-up visits to specialists [
4]. Moreover, they need to adapt to changes in social roles and relationships, manage emotions, and establish new perspectives in life [
5,
6]. Therefore, KTRs face various challenges in completing the self-management tasks after kidney transplantation. KTRs reported difficulties in self-management and lacked guidance on effective self-management knowledge and skills [
7,
8]. Ineffective self-management compromises the quality of life, increases medical costs, and affects the survival rate of KTRs [
9‐
11]. Therefore, self-management support is necessary for KTRs to better perform self-management tasks and improve their health outcomes.
The concept of self-management support was first proposed by Creer [
12] and was widely used in the management of chronic diseases, such as diabetes, cardiovascular and cerebrovascular diseases, organ transplantation, hypertension, and cancer. However, self-management support for KTRs has not been clearly defined. According to the definition of diabetes self-management support by the American Diabetes Association (ADA) [
13], we could define the self-management support of KTRs as activities that help KTRs achieve and maintain their self-management behaviors. The types of support mainly include instrumental support, that is, disease-related medical management; psychosocial support, which refers to emotional and psychological resources needed to manage the disease and relational support, the beneficial interaction with others [
14]. Self-management support comes from a wide range of sources, including medical staff, disease management educators, community health service personnel, governments, organizations, families, relatives, friends and other KTRs [
14]. It mainly includes the development of behavioural objectives, education about self-management knowledge, good medication management, psychosocial support, economic and medical policy support, and regular follow-up and examination reminders [
15‐
18]. Previous studies have reported that self-management support significantly improved KTRs’ self-management skills, enhancing their medication adherence [
15], and quality of life [
19], underscoring the importance of offering self-management support in the care trajectory of KTRs.
However, Been-Dahmen [
20] and Grijpma [
21] found that KTRs’ needs for self-management support are not the same. They called for adequate tools to examine KTRs’ self-management support needs so that the medical staff can tailor self-management support interventions. Researchers have mentioned self-management support in a variety of ways, including, but not limited to, perceived support [
20], received support [
22] and provided support [
23], among which the evaluation of support received by patients from their perspectives is expected to provide valuable information for future interventions. A scale to measure the amount of self-management support received and further identify patients’ unmet needs is necessary. However, such a scale for KTRs is lacking, leaving a field of research open for further exploration. To fill this gap, our study aimed to develop a Self-management Support Scale for Kidney Transplant Recipients (SMSSKTR) and test its psychometric properties.
Discussion
Assessing the self-management support received by KTRs helps medical staff to identify self-management support KTRs lack and tailor interventions accordingly. The purpose of this study was to develop and psychometrically evaluate an instrument to assess received self-management support for KTRs, namely, SMSSKTR. We followed the recommendations of Rattray and Jones [
24] to ensure that the scale was scientifically developed. The final product is a 5-point Likert scale that includes three dimensions and 22 items. The total score ranges from 22 to 110, with higher scores indicating more self-management support received by KTRs. SMSSKTR is one of the first instruments with adequate psychometric properties to evaluate self-management support received by KTRs.
The construct validity of SMSSKTR was evaluated by EFA, followed by CFA. The results of the EFA revealed a three-factor structure explaining 66% of the total variance, which was within the recommended range for multidimensional scales [
40]. This indicates that SMSSKTR provides adequate coverage for evaluating the self-management support received by KTRs. This structure was further confirmed by CFA, which met our expectation about the structure of SMSSKTR. In Stage 1, we proposed the definition of self-management support for KTRs and its dimensions according to ADA [
13], the Chronic Care Model [
26], and the thematic synthesis of self-management support for patients with chronic conditions [
14]. Using the definition and dimensions as a guide, we formed the initial items by extracting them from the literature, relevant scales and themes of interview transcripts. Next, we invited experts for the suitability of the items and performed a statistical analysis to screen items of the initial scale. All of these steps ensured the theoretical soundness of SMSSKTR. The three-factor structure indicated that the self-management support of KTRs was a multifaceted and multidimensional concept, which was in line with the current trends of integration of the full care team for chronic diseases [
41]. Our results showed that the score of SMSSKTR, SMSRTR and their subscales were positively correlated, which was consistent with the finding of Sim et al. [
38] and our hypothesis that healthcare professionals’ support was positively correlated with patients’ self-management, providing evidence for the convergent validity.
Factor 1 is labelled “instrumental support”, referring to disease-related medical management KTRs received from the medical staff. This dimension includes nine items accounting for 25.9% of the total variance, covering topics such as received support for daily life care and self-management of post-transplantation complications, treatment plans, and side effects of medication. As mentioned earlier, KTRs must deal with rejection and complications induced by transplantation. Therefore, medication management is a key element. However, Ranahan et al. [
42] found that very few KTRs felt confident when explaining how their medications worked, expressing that this information ‘was above their head’, and many felt unprepared for the pill burden, side effects, doses, and medication management encountered after transplantation. These findings highlight the importance of receiving medical management support. Our scale offers a way to check the extent to which KTRs have already received this kind of support and therefore, identify their unmet needs.
Factor 2 is labelled “psychosocial support”, referring to the emotional and psychological resources needed to manage the disease. This dimension includes nine items and accounts for 24.5% of the total variance, asking about the extent to which KTRs have received this kind of support from a variety of sources, not only from professionals but also from people around them, such as peers, family, friends, and colleagues. As suggested by Chisholm-Burns et al. [
43], involving family members and/or friends as a support system would facilitate self-management adherence. Therefore, the support sources should vary. As pointed out by Been-Dahmen et al. [
20], KTRs’ emotional and social support needs were usually overlooked. Rating the nine items in the psychosocial support dimension would not only check the amount of psychosocial support received but also raise the awareness of the medical staff regarding providing this kind of support.
Factor 3 is labelled “relational support”, referring to beneficial interaction with others. Although this dimension has only four items and accounts for 15.6% of the total variance, it is the centre of patients’ support needs and provides motivation for other types of support [
14]. On one hand, the medical staff show respects towards KTRs when making plans; On the other hand, medical staff, family, friends, and colleagues show understanding and support towards KTRs. It is necessary to consider patients’ thoughts when developing a treatment plan, which is beneficial to improve KTRs’ adherence [
43]. One-way communication hinders effective partnerships necessary for disease management [
44]. The four items in the relational support dimension help identify the extent to which KTRs have received this kind of beneficial interaction.
As for the reliability, Cronbach’s alpha coefficient for the entire scale was 0.959 and ranged from 0.956 to 0.958 for its three subscales, showing excellent internal consistency of SMSSKTR. The corrected item-total correlation coefficient ranged from 0.62 to 0.82, indicating acceptable associations. The ICC value reached 0.915 when assessing the test-retest reliability, indicating excellent reliability and time stability [
45].
Strength and limitation
To the best of our knowledge, SMSSKTR is one of the first instruments to assess the self-management support received by KTRs. We followed the recommendations for scale design and development proposed by Rattray and Jones [
24] to ensure scientific development and validation procedures. However, this study has several major limitations. First, due to the difficulties of following up participants during the COVID-19 pandemic, data for calculating the test-retest reliability were missing in Stage 3. We can only rely on the data obtained in Stage 2 instead of Stage 3 to calculate the test-retest reliability. Fortunately, we had 30 KTRs to fill in SMSSKTR twice in Stage 2, and the 22 items supposed to be used to calculate the test-retest reliability remained the same in the two stages, which made the calculation possible and scientific. Second, the participants responded to questionnaires during their outpatient visits. This might have affected their answers to the items because of their busy schedules. Thirdly, although the sample size in our study was sufficient to perform EFA and CFA, it was not large enough to carry out the statistical analysis to set the cutoff point for SMSSKTR. Further research is required in this regard. Finally, we developed the scale based on Wagner’s Chronic Care Model. Therefore, items regarding digitalization/eHealth were removed when the scale was finalized. It would be of great importance to modify our scale based on the eHealth Enhanced Chronic Care Model [
46] in future study to reflect this trend.
Conclusion
Using the three-stage design, our study shows that SMSSKTR has good reliability and validity, indicating that it can be used as an evaluation tool to measure the amount of self-management support received and clarify what self-management support KTRs lack, thus providing guidance for medical staff, families, friends, and colleagues to support KTRs in a timely and targeted manner, and ultimately improving their self-management and health outcomes. Given the general nature of the items in SMSSKTR, it will be of great significance to validate this scale to other transplant patient groups in the future.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.